Institutional readiness to provide critical care to patients with viral hemorrhagic fever (VHF) in the United States after the COVID-19 pandemic
Most responding SPTCs reported capability for critical care interventions, although fewer had policies governing code status, ECMO, and cricothyrotomy. Institutions were less prepared to manage a VHF patient after the COVID-19 pandemic, highlighting challenges such as staff turnover and less support for training and equipment maintenance. Given that special pathogen outbreaks continue to occur globally, governments and healthcare institutions should institute measures to recruit, support, and retain staff to ensure critical care readiness for special pathogen patients.
Authors
- Jocelyn J. Herstein (ORCID: https://orcid.org/0000-0003-3686-1198)
- Radu Postelnicu (ORCID: https://orcid.org/0000-0003-1244-3848)
- Wael ElRayes (ORCID: https://orcid.org/0000-0002-8059-5061)
- Vikram Mukherjee
- Angela Vasa (ORCID: https://orcid.org/0000-0003-3473-5905)
- Anthony J. Lo Piccolo (ORCID: https://orcid.org/0000-0001-5618-8645)
- Madeline A. DiLorenzo (ORCID: https://orcid.org/0000-0003-1284-6428)
Institutions
- New York City Health and Hospitals Corporation (US)
- Nebraska Medical Center (US)
- NYU Langone Health (US)
- Bellevue Hospital Center (US)
- Center for Global Health (US)
- New York University (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.10167
- Citations
- 1
- Primary Topic
- Disaster Response and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.52
Funders
- Amgen
- Gilead Sciences
- Biogen
- University of Nebraska Medical Center
- Vertex Pharmaceuticals
- Jazz Pharmaceuticals
- Humana
- Quest Diagnostics
- CVS Health
- ResMed